Safety and Efficacy of Ex Vivo Expanded Healthy Donor-Derived Double Negative T Cells for the Treatment of AML Relapsed after Allogeneic Stem Cell Transplantation: A First in-Human Phase I/IIa Clinical Trial

被引:11
|
作者
Baolin, Tang
Lee, Jongbok
Cheng, Siqi
Yao, Wen
Wang, Dongyao
Tu, Meijuan
Xiang, Zhiqiang
Geng, Liangquan
Wang, Mingxia
Qiang, Ping
Teng, Pingping
Sun, Guangyu
Pan, Tianzhong
Liu, Huilan
Yang, Liming
Sun, Zimin
Zhang, Li
Zhu, Xiaoyu
机构
关键词
D O I
10.1182/blood-2020-141505
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [11] Allogeneic double-negative T cell therapy for relapsed acute myeloid leukemia patients post allogeneic hematopoietic stem cell transplantation: A first-in-human phase I study
    Tang, Baolin
    Lee, Jong Bok
    Cheng, Siqi
    Pan, Tianzhong
    Yao, Wen
    Wang, Dongyao
    Tu, Meijuan
    Xiang, Zhiqiang
    Chu, Xiandeng
    Geng, Liangquan
    Qiang, Ping
    Teng, Pingping
    Sun, Guangyu
    Liu, Huilan
    Wang, Jian
    Schimmer, Aaron D.
    Yang, Liming
    Sun, Zimin
    Zhang, Li
    Zhu, Xiaoyu
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (07) : E264 - E267
  • [12] Adoptive Transfer of Purified Donor-B-Lymphocytes after Allogeneic Stem Cell Transplantation: Results from a Phase I/IIa Clinical Trial
    Winkler, Julia
    Tittlbach, Hannes
    Roesler, Wolf
    Strobel, Julian
    Zimmermann, Roland
    Maas, Stefanie
    Spriewald, Bernd
    Wolff, Daniel
    Repp, Roland
    Kordelas, Lambros
    Mach, Michael
    Mackensen, Andreas
    Winkler, Thomas H.
    BLOOD, 2016, 128 (22)
  • [13] Infusion Of Donor-Derived CD19-Redirected-Virus-Specific T Cells For B-Cell Malignancies Relapsed After Allogeneic Stem Cell Transplant: A Phase I Study
    Cruz, Conrad Russell Y.
    Micklethwaite, Kenneth P.
    Savoldo, Barbara
    Ramos, Carlos A.
    Lam, Sharon
    Ku, Stephanie
    Diouf, Oumar
    Liu, Enli
    Barrett, A. John
    Ito, Sawa
    Shpall, Elizabeth J.
    Krance, Robert A.
    Kamble, Rammurti T.
    Carrum, George
    Hosing, Chitra M.
    Gee, Adrian P.
    Mei, Zhuyong
    Grilley, Bambi J.
    Heslop, Helen E.
    Rooney, Cliona M.
    Brenner, Malcolm K.
    Bollard, Catherine M.
    Dotti, Gianpietro
    BLOOD, 2013, 122 (21)
  • [14] Repeated infusions of donor-derived cytokine-induced killer cells in patients relapsing after allogeneic stem cell transplantation: a phase I study
    Introna, Martino
    Borleri, Gianmaria
    Conti, Elena
    Franceschetti, Marta
    Barbui, Anna Maria
    Broady, Raewyn
    Dander, Erica
    Gaipa, Giuseppe
    D'Amico, Giovanna
    Biagi, Ettore
    Parma, Matteo
    Pogliani, Enrico M.
    Spinelli, Orietta
    Baronciani, Donatella
    Grassi, Anna
    Golay, Josee
    Barbui, Tiziano
    Biondi, Andrea
    Rambaldi, Alessandro
    HAEMATOLOGICA, 2007, 92 (07) : 952 - 959
  • [15] Safety and efficacy of an allogeneic adipose-derived mesenchymal stem cell preparation in the treatment of knee osteoarthritis: A Phase I/IIa randomised controlled trial
    Freitag, Julien
    Chamberlain, Matthew
    Wickham, James
    Shah, Kiran
    Cicuttini, Flavia
    Wang, Yuanyuan
    Solterbeck, Ann
    OSTEOARTHRITIS AND CARTILAGE OPEN, 2024, 6 (03):
  • [16] Phase 1 clinical trial using mbIL21 ex vivo-expanded donor-derived NK cells after haploidentical transplantation (vol 130, pg 1857, 2017)
    Ciurea, S. O.
    Schafer, J. R.
    Bassett, R.
    BLOOD, 2018, 132 (26) : 2782 - 2782
  • [17] Donor-Derived Ex-Vivo Activated NK Cells in Management of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in High-Risk Acute Leukemia
    Cao, Xing-Yu
    Wu, Tong
    Deng, Bi-Ping
    Sun, Rui-Juan
    Lu, Yue
    Zhao, Yan-Li
    Zhang, Jian-Ping
    Zhou, Jia-Rui
    Wei, Zhi-Jie
    Tao, Xiu-Yan
    Wang, Hui
    Liu, Hong-Xing
    Lu, Dao-Pei
    Tong, Chun-Rong
    BLOOD, 2014, 124 (21)
  • [18] Allogeneic Donor-Derived CD19-Chimeric Antigen Receptor (CAR) T Cells for Relapsed B-Cell Malignancies After Hematopoietic Stem Cell Transplantation
    Muhsen, Ibrahim N.
    Cruz, Helton
    Zhang, Huimin
    Thakkar, Sachin G.
    Grilley, Bambi
    Gee, Adrian P.
    Heslop, Helen E.
    Brenner, Malcolm K.
    Ramos, Carlos A.
    MOLECULAR THERAPY, 2022, 30 (04) : 227 - 227
  • [19] ALLOGENEIC DONOR-DERIVED CD19-CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS FOR RELAPSED B-CELL MALIGNANCIES AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
    Muhsen, I. N.
    Cruz, H.
    Zhang, H.
    Thakkar, S. G.
    Grilley, B.
    Gee, A. P.
    Heslop, H.
    Brenner, M.
    Ramos, C. A.
    CYTOTHERAPY, 2022, 24 (05) : S27 - S28
  • [20] Phase I Trial of Prophylactic Donor-Derived IL-2-Activated NK Cell Infusion after Allogeneic Hematopoietic Stem Cell Transplantation from a Matched Sibling Donor
    Devillier, Raynier
    Calmels, Boris
    Guia, Sophie
    Taha, Mohammed
    Fauriat, Cyril
    Mfarrej, Bechara
    Venton, Geoffroy
    Vivier, Eric
    Olive, Daniel
    Chabannon, Christian
    Blaise, Didier
    Ugolini, Sophie
    CANCERS, 2021, 13 (11)